期刊文献+

人用狂犬病灭活疫苗的临床研究和应用 被引量:5

原文传递
导出
摘要 狂犬病疫苗是预防狂犬病的安全有效方法。本文从人二倍体细胞疫苗、纯化 Vero 细胞狂犬病疫苗、层析纯化狂犬病疫苗的临床研究角度,概述此类广泛应用的人用狂犬病疫苗的优缺点、国内外的发展过程和临床免疫效果,以及我国当前对氢氧化铝佐剂疫苗和无佐剂疫苗的临床研究热点。数据显示国产无佐剂疫苗引起的不良反应发生率和抗体阳转率与进口同类疫苗相近,这类疫苗预防狂犬病的免疫效果是有保证的。
出处 《国际生物制品学杂志》 CAS 2007年第6期259-263,共5页 International Journal of Biologicals
  • 相关文献

参考文献23

  • 1Anderson MC, Baer H,Frazier DJ,et al. The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine. J Allergy Clin Immunol, 1987,80(6) :861-868. 被引量:1
  • 2Swanson MC,Rosanoff E,Gurwith M,et al. IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. J Infect Dis, 1987,155(5) :909-913. 被引量:1
  • 3Bahmanyar M. Results of rabies post-exposure treatment with antirabies serum and the human diploid cell vaccine in Iran. Dev Biol Stand, 1978,40:163-165. 被引量:1
  • 4Fayaz A, Simani S, Nour-Salehi S, et al. Booster effect of human diploid cell antirabies vaccine in previously treated persons. JAMA, 1981,246(20) :2334-2335. 被引量:1
  • 5Nicholson KG,Turner G S, Aoki FY. Immunization with a human diploid cell strain of rabies virus vaccine:two-year results. J Infect Dis,1978,137(6):783-788. 被引量:1
  • 6Rodrigues FM, Mandke VB,Roumiantzeff M,et al. Persistence of rabies antibody 5 years after preexposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose. Epidemiol Infect, 1987,99 ( 1 ) : 91-95. 被引量:1
  • 7Bahmanyar M, Fayaz A, Nour-Salehi S, et al. Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA, 1976,236(24) : 2751-2754. 被引量:1
  • 8Dureux B,Canton P,Gerard A,et al. Rabies vaccine for human use,cultivated on Vero cells. Lancet,1986,2(8498) :98. 被引量:1
  • 9Svjetlicic M,Vodopija I,Smerdel S,et al. Compatibility and immunogenicity of erieux a purified vero rabies vaccine (PVRV) in healthy subjects // Vodopija I, Nicholson KG, Smerdel S, et al. Improvements in rabies post-exposure treatment. Zagreb Institute of Public Health, 1985 : 123-127. 被引量:1
  • 10Suntharasamai P, Warrell M J, Warrell DA, et al. New purified Vero-cell vaccine prevents rabies in patients bitten by rabid animals. Lancet, 1986,2(8499) :129-131. 被引量:1

二级参考文献38

  • 1张永振.中国狂犬病的流行病学[J].中国计划免疫,2005,11(2):140-143. 被引量:121
  • 2李宏玲,李河卫,俞永新,严子林.狂犬病毒在Vero细胞上的传代适应[J].中国人兽共患病杂志,1989,5(6):14-16. 被引量:7
  • 3陆隆沫 曾繁珍 等.地鼠肾组织培养狂犬病灭活疫苗健康人群接种反应观察和血清抗体测定[J].病毒学集刊,1982,2:81-82. 被引量:4
  • 4陆裕宽,唐小萍,陆家华,吴泰才,李冲之,杜双兰,范培芳.浓缩狂犬病疫苗接种后不良反应与血清抗体水平分析[J].微生物学免疫学进展,1997,25(1):36-39. 被引量:9
  • 5肖泽帅 阎长青 俞永新.狂犬固定病毒人二倍体细胞适应株生物学性质的研究[J].中华微生物学和免疫学杂志,1981,1(4):245-250. 被引量:2
  • 6WHO Expert Committee on Rabies.Eighth Repot,1992. 被引量:1
  • 7Thongcharocn PW,Chaiprasithikul P,Lamkon R,et al.Immunogenicity of Purified Vero Cell rabies Vaccine.Virus inf Exch Newsl SE.Asia,1986,3:80. 被引量:1
  • 8Fishbein D,Yenne K,Dreesen D.Risk factors for systemic hypersensitivity reactions after booster vaccination with human diploid cells rabies vaccine.A nation wide prospective study.Vaccine,1993,11:1390-1394. 被引量:1
  • 9Scheiermann N,Bear J,Hiffenhaus J,et al.Reactogenicity and immunogenicity of the newly developed purified chick embryo cell(PCEC) rabies vaccine in man.Zbl Bakt Hyg.A,1987,265:439-450. 被引量:1
  • 10唐青 赵秀芹 陈化新.我国狂犬病流行概况[J].疾病监测,1999,14(12):3-6. 被引量:2

共引文献60

同被引文献24

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部